| ■ 영문 제목 : Global Non Hodgkin Lymphoma (NHL) Market Growth (Status and Outlook) 2021-2026 | |
 | ■ 상품코드 : LPI-2201K02109 ■ 조사/발행회사 : LP Information ■ 발행일 : 2021년 12월 (※2025년 최신판이 있습니다. 문의 주세요.) ■ 페이지수 : 87 ■ 작성언어 : 영어 ■ 보고서 형태 : PDF ■ 납품 방식 : E메일 ■ 조사대상 지역 : 글로벌 ■ 산업 분야 : 의약품 |
| Single User (1명 열람용) | USD3,660 ⇒환산￦4,941,000 | 견적의뢰/주문/질문 |
| Multi User (5명 열람용) | USD5,490 ⇒환산￦7,411,500 | 견적의뢰/주문/질문 |
| Corporate User (동일기업내 공유가능) | USD7,320 ⇒환산￦9,882,000 | 견적의뢰/구입/질문 |
|
※가격옵션 설명 - 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다. - 지불방법은 계좌이체/무통장입금 또는 카드결제입니다. |
| 본 조사보고서는 비호지킨 림프종 (NHL)의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아, 러시아, 중동/아프리카, 이집트, 남아프리카, 터키, 중동GCC국 등), 시장동향, 판매/유통업자/고객 리스트, 시장예측 (2021년-2026년), 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) 등의 정보를 포함하고 있습니다. 또한, 주요지역의 종류별 시장규모 (표준, 우수)와 용도별 시장규모 (병원, 클리닉) 데이터도 수록되어 있습니다. - 조사 범위 - 경영자용 요약 - 기업별 비호지킨 림프종 (NHL) 시장 점유율 - 지역별 비호지킨 림프종 (NHL) 시장규모 - 주요지역의 종류별 시장규모 (표준, 우수) - 주요지역의 용도별 시장규모 (병원, 클리닉) - 미주의 비호지킨 림프종 (NHL) 시장규모 (미국, 캐나다, 멕시코, 브라질 등) - 아시아의 비호지킨 림프종 (NHL) 시장규모 (중국, 일본, 한국, 동남아시아, 인도 등) - 유럽의 비호지킨 림프종 (NHL) 시장규모 (독일, 프랑스, 영국, 이탈리아, 러시아 등) - 중동/아프리카의 비호지킨 림프종 (NHL) 시장규모 (이집트, 남아프리카, 터키, 중동GCC지역 등) - 시장의 성장요인, 과제, 동향 - 마케팅, 유통업자, 고객리스트 - 세계의 비호지킨 림프종 (NHL) 시장예측 (2021년-2026년) - 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) F. Hoffmann-La Roche, Johnson & Johnson, Merck, Bristol Myers Squibb, Celgene, Eli Lilly, GlaxoSmithKline, Bayer - 조사의 결과/결론 |
According to this latest study, the 2021 growth of Non Hodgkin Lymphoma (NHL) will have significant change from previous year. By the most conservative estimates of global Non Hodgkin Lymphoma (NHL) market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Non Hodgkin Lymphoma (NHL) market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026.
This report presents a comprehensive overview, market shares, and growth opportunities of Non Hodgkin Lymphoma (NHL) market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2016 to 2021 in Section 2.3; and forecast to 2026 in section 10.7.
Standard
Exellent
Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 10.8.
Hosptial
Clinic
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
F. Hoffmann-La Roche
Johnson & Johnson
Merck
Bristol Myers Squibb
Celgene
Eli Lilly
GlaxoSmithKline
Bayer
1 Scope of the Report 2 Executive Summary 3 Non Hodgkin Lymphoma (NHL) Market Size by Players 4 Non Hodgkin Lymphoma (NHL) by Regions 5 Americas 6 APAC 7 Europe 8 Middle East & Africa 9 Market Drivers, Challenges and Trends 10 Global Non Hodgkin Lymphoma (NHL) Market Forecast 11 Key Players Analysis 12 Research Findings and Conclusion List of TablesTable 1. Non Hodgkin Lymphoma (NHL) Market Size CAGR by Region (2020-2026) & ($ Millions) Table 2. Major Players of Standard Table 3. Major Players of Exellent Table 4. Non Hodgkin Lymphoma (NHL) Market Size CAGR by Type (2020-2026) & ($ Millions) Table 5. Global Non Hodgkin Lymphoma (NHL) Market Size by Type (2016-2021) & ($ Millions) Table 6. Global Non Hodgkin Lymphoma (NHL) Market Size Market Share by Type (2016-2021) Table 7. Non Hodgkin Lymphoma (NHL) Market Size CAGR by Application (2016-2021) & ($ Millions) Table 8. Global Non Hodgkin Lymphoma (NHL) Market Size by Application (2016-2021) & ($ Millions) Table 9. Global Non Hodgkin Lymphoma (NHL) Market Size Market Share by Application (2016-2021) Table 10. Global Non Hodgkin Lymphoma (NHL) Revenue by Players (2019-2021E) & ($ Millions) Table 11. Global Non Hodgkin Lymphoma (NHL) Revenue Market Share by Players (2019-2021E) Table 12. Non Hodgkin Lymphoma (NHL) Key Players Head office and Products Offered Table 13. Non Hodgkin Lymphoma (NHL) Concentration Ratio (CR3, CR5 and CR10) & (2019-2021E) Table 14. New Products and Potential Entrants Table 15. Mergers & Acquisitions, Expansion Table 16. Global Non Hodgkin Lymphoma (NHL) Market Size by Regions 2016-2021 & ($ Millions) Table 17. Global Non Hodgkin Lymphoma (NHL) Market Size Market Share by Regions 2016-2021 Table 18. Americas Non Hodgkin Lymphoma (NHL) Market Size by Country (2016-2021) & ($ Millions) Table 19. Americas Non Hodgkin Lymphoma (NHL) Market Size Market Share by Country (2016-2021) Table 20. Americas Non Hodgkin Lymphoma (NHL) Market Size by Type (2016-2021) & ($ Millions) Table 21. Americas Non Hodgkin Lymphoma (NHL) Market Size Market Share by Type (2016-2021) Table 22. Americas Non Hodgkin Lymphoma (NHL) Market Size by Application (2016-2021) & ($ Millions) Table 23. Americas Non Hodgkin Lymphoma (NHL) Market Size Market Share by Application (2016-2021) Table 24. APAC Non Hodgkin Lymphoma (NHL) Market Size by Region (2016-2021) & ($ Millions) Table 25. APAC Non Hodgkin Lymphoma (NHL) Market Size Market Share by Region (2016-2021) Table 26. APAC Non Hodgkin Lymphoma (NHL) Market Size by Type (2016-2021) & ($ Millions) Table 27. APAC Non Hodgkin Lymphoma (NHL) Market Size Market Share by Type (2016-2021) Table 28. APAC Non Hodgkin Lymphoma (NHL) Market Size by Application (2016-2021) & ($ Millions) Table 29. APAC Non Hodgkin Lymphoma (NHL) Market Size Market Share by Application (2016-2021) Table 30. Europe Non Hodgkin Lymphoma (NHL) Market Size by Country (2016-2021) & ($ Millions) Table 31. Europe Non Hodgkin Lymphoma (NHL) Market Size Market Share by Country (2016-2021) Table 32. Europe Non Hodgkin Lymphoma (NHL) Market Size by Type (2016-2021) & ($ Millions) Table 33. Europe Non Hodgkin Lymphoma (NHL) Market Size Market Share by Type (2016-2021) Table 34. Europe Non Hodgkin Lymphoma (NHL) Market Size by Application (2016-2021) & ($ Millions) Table 35. Europe Non Hodgkin Lymphoma (NHL) Market Size Market Share by Application (2016-2021) Table 36. Middle East & Africa Non Hodgkin Lymphoma (NHL) Market Size by Region (2016-2021) & ($ Millions) Table 37. Middle East & Africa Non Hodgkin Lymphoma (NHL) Market Size Market Share by Region (2016-2021) Table 38. Middle East & Africa Non Hodgkin Lymphoma (NHL) Market Size by Type (2016-2021) & ($ Millions) Table 39. Middle East & Africa Non Hodgkin Lymphoma (NHL) Market Size Market Share by Type (2016-2021) Table 40. Middle East & Africa Non Hodgkin Lymphoma (NHL) Market Size by Application (2016-2021) & ($ Millions) Table 41. Middle East & Africa Non Hodgkin Lymphoma (NHL) Market Size Market Share by Application (2016-2021) Table 42. Key and Potential Regions of Non Hodgkin Lymphoma (NHL) Table 43. Key Application and Potential Industries of Non Hodgkin Lymphoma (NHL) Table 44. Key Challenges of Non Hodgkin Lymphoma (NHL) Table 45. Key Trends of Non Hodgkin Lymphoma (NHL) Table 46. Global Non Hodgkin Lymphoma (NHL) Market Size Forecast by Regions (2021-2026) & ($ Millions) Table 47. Global Non Hodgkin Lymphoma (NHL) Market Size Market Share Forecast by Regions (2021-2026) Table 48. Global Non Hodgkin Lymphoma (NHL) Market Size Forecast by Type (2021-2026) & ($ Millions) Table 49. Global Non Hodgkin Lymphoma (NHL) Market Size Market Share Forecast by Type (2021-2026) Table 50. Global Non Hodgkin Lymphoma (NHL) Market Size Forecast by Application (2021-2026) & ($ Millions) Table 51. Global Non Hodgkin Lymphoma (NHL) Market Size Market Share Forecast by Application (2021-2026) Table 52. F. Hoffmann-La Roche Details, Company Type, Non Hodgkin Lymphoma (NHL) Area Served and Its Competitors Table 53. F. Hoffmann-La Roche Non Hodgkin Lymphoma (NHL) Product Offered Table 54. F. Hoffmann-La Roche Non Hodgkin Lymphoma (NHL) Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 55. F. Hoffmann-La Roche Main Business Table 56. F. Hoffmann-La Roche Latest Developments Table 57. Johnson & Johnson Details, Company Type, Non Hodgkin Lymphoma (NHL) Area Served and Its Competitors Table 58. Johnson & Johnson Non Hodgkin Lymphoma (NHL) Product Offered Table 59. Johnson & Johnson Main Business Table 60. Johnson & Johnson Non Hodgkin Lymphoma (NHL) Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 61. Johnson & Johnson Latest Developments Table 62. Merck Details, Company Type, Non Hodgkin Lymphoma (NHL) Area Served and Its Competitors Table 63. Merck Non Hodgkin Lymphoma (NHL) Product Offered Table 64. Merck Main Business Table 65. Merck Non Hodgkin Lymphoma (NHL) Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 66. Merck Latest Developments Table 67. Bristol Myers Squibb Details, Company Type, Non Hodgkin Lymphoma (NHL) Area Served and Its Competitors Table 68. Bristol Myers Squibb Non Hodgkin Lymphoma (NHL) Product Offered Table 69. Bristol Myers Squibb Main Business Table 70. Bristol Myers Squibb Non Hodgkin Lymphoma (NHL) Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 71. Bristol Myers Squibb Latest Developments Table 72. Celgene Details, Company Type, Non Hodgkin Lymphoma (NHL) Area Served and Its Competitors Table 73. Celgene Non Hodgkin Lymphoma (NHL) Product Offered Table 74. Celgene Main Business Table 75. Celgene Non Hodgkin Lymphoma (NHL) Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 76. Celgene Latest Developments Table 77. Eli Lilly Details, Company Type, Non Hodgkin Lymphoma (NHL) Area Served and Its Competitors Table 78. Eli Lilly Non Hodgkin Lymphoma (NHL) Product Offered Table 79. Eli Lilly Main Business Table 80. Eli Lilly Non Hodgkin Lymphoma (NHL) Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 81. Eli Lilly Latest Developments Table 82. GlaxoSmithKline Details, Company Type, Non Hodgkin Lymphoma (NHL) Area Served and Its Competitors Table 83. GlaxoSmithKline Non Hodgkin Lymphoma (NHL) Product Offered Table 84. GlaxoSmithKline Main Business Table 85. GlaxoSmithKline Non Hodgkin Lymphoma (NHL) Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 86. GlaxoSmithKline Latest Developments Table 87. Bayer Details, Company Type, Non Hodgkin Lymphoma (NHL) Area Served and Its Competitors Table 88. Bayer Non Hodgkin Lymphoma (NHL) Product Offered Table 89. Bayer Main Business Table 90. Bayer Non Hodgkin Lymphoma (NHL) Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 91. Bayer Latest Developments List of Figures Figure 1. Non Hodgkin Lymphoma (NHL) Report Years Considered Figure 2. Research Objectives Figure 3. Research Methodology Figure 4. Research Process and Data Source Figure 5. Global Non Hodgkin Lymphoma (NHL) Market Size Growth Rate 2016-2026 ($ Millions) Figure 6. Global Non Hodgkin Lymphoma (NHL) Market Size Market Share by Type in 2020 Figure 7. Non Hodgkin Lymphoma (NHL) in Hosptial Figure 8. Global Non Hodgkin Lymphoma (NHL) Market: Hosptial (2016-2021) & ($ Millions) Figure 9. Non Hodgkin Lymphoma (NHL) in Clinic Figure 10. Global Non Hodgkin Lymphoma (NHL) Market: Clinic (2016-2021) & ($ Millions) Figure 11. Global Non Hodgkin Lymphoma (NHL) Market Size Market Share by Application in 2020 Figure 12. Global Non Hodgkin Lymphoma (NHL) Revenue Market Share by Player in 2020 Figure 13. Global Non Hodgkin Lymphoma (NHL) Market Size Market Share by Regions (2016-2021) Figure 14. Americas Non Hodgkin Lymphoma (NHL) Market Size 2016-2021 ($ Millions) Figure 15. APAC Non Hodgkin Lymphoma (NHL) Market Size 2016-2021 ($ Millions) Figure 16. Europe Non Hodgkin Lymphoma (NHL) Market Size 2016-2021 ($ Millions) Figure 17. Middle East & Africa Non Hodgkin Lymphoma (NHL) Market Size 2016-2021 ($ Millions) Figure 18. Americas Non Hodgkin Lymphoma (NHL) Market Size Market Share by Country in 2020 Figure 19. Americas Non Hodgkin Lymphoma (NHL) Market Size Market Share by Type in 2020 Figure 20. Americas Non Hodgkin Lymphoma (NHL) Market Size Market Share by Application in 2020 Figure 21. United States Non Hodgkin Lymphoma (NHL) Market Size Growth 2016-2021 ($ Millions) Figure 22. Canada Non Hodgkin Lymphoma (NHL) Market Size Growth 2016-2021 ($ Millions) Figure 23. Mexico Non Hodgkin Lymphoma (NHL) Market Size Growth 2016-2021 ($ Millions) Figure 24. APAC Non Hodgkin Lymphoma (NHL) Market Size Market Share by Regions in 2020 Figure 25. APAC Non Hodgkin Lymphoma (NHL) Market Size Market Share by Type in 2020 Figure 26. APAC Non Hodgkin Lymphoma (NHL) Market Size Market Share by Application in 2020 Figure 27. China Non Hodgkin Lymphoma (NHL) Market Size Growth 2016-2021 ($ Millions) Figure 28. Japan Non Hodgkin Lymphoma (NHL) Market Size Growth 2016-2021 ($ Millions) Figure 29. Korea Non Hodgkin Lymphoma (NHL) Market Size Growth 2016-2021 ($ Millions) Figure 30. Southeast Asia Non Hodgkin Lymphoma (NHL) Market Size Growth 2016-2021 ($ Millions) Figure 31. India Non Hodgkin Lymphoma (NHL) Market Size Growth 2016-2021 ($ Millions) Figure 32. Australia Non Hodgkin Lymphoma (NHL) Market Size Growth 2016-2021 ($ Millions) Figure 33. Europe Non Hodgkin Lymphoma (NHL) Market Size Market Share by Country in 2020 Figure 34. Europe Non Hodgkin Lymphoma (NHL) Market Size Market Share by Type in 2020 Figure 35. Europe Non Hodgkin Lymphoma (NHL) Market Size Market Share by Application in 2020 Figure 36. Germany Non Hodgkin Lymphoma (NHL) Market Size Growth 2016-2021 ($ Millions) Figure 37. France Non Hodgkin Lymphoma (NHL) Market Size Growth 2016-2021 ($ Millions) Figure 38. UK Non Hodgkin Lymphoma (NHL) Market Size Growth 2016-2021 ($ Millions) Figure 39. Italy Non Hodgkin Lymphoma (NHL) Market Size Growth 2016-2021 ($ Millions) Figure 40. Russia Non Hodgkin Lymphoma (NHL) Market Size Growth 2016-2021 ($ Millions) Figure 41. Middle East & Africa Non Hodgkin Lymphoma (NHL) Market Size Market Share by Region in 2020 Figure 42. Middle East & Africa Non Hodgkin Lymphoma (NHL) Market Size Market Share by Type in 2020 Figure 43. Middle East & Africa Non Hodgkin Lymphoma (NHL) Market Size Market Share by Application in 2020 Figure 44. Egypt Non Hodgkin Lymphoma (NHL) Market Size Growth 2016-2021 ($ Millions) Figure 45. South Africa Non Hodgkin Lymphoma (NHL) Market Size Growth 2016-2021 ($ Millions) Figure 46. Israel Non Hodgkin Lymphoma (NHL) Market Size Growth 2016-2021 ($ Millions) Figure 47. Turkey Non Hodgkin Lymphoma (NHL) Market Size Growth 2016-2021 ($ Millions) Figure 48. GCC Country Non Hodgkin Lymphoma (NHL) Market Size Growth 2016-2021 ($ Millions) Figure 49. Americas Non Hodgkin Lymphoma (NHL) Market Size 2021-2026 ($ Millions) Figure 50. APAC Non Hodgkin Lymphoma (NHL) Market Size 2021-2026 ($ Millions) Figure 51. Europe Non Hodgkin Lymphoma (NHL) Market Size 2021-2026 ($ Millions) Figure 52. Middle East & Africa Non Hodgkin Lymphoma (NHL) Market Size 2021-2026 ($ Millions) Figure 53. United States Non Hodgkin Lymphoma (NHL) Market Size 2021-2026 ($ Millions) Figure 54. Canada Non Hodgkin Lymphoma (NHL) Market Size 2021-2026 ($ Millions) Figure 55. Mexico Non Hodgkin Lymphoma (NHL) Market Size 2021-2026 ($ Millions) Figure 56. Brazil Non Hodgkin Lymphoma (NHL) Market Size 2021-2026 ($ Millions) Figure 57. China Non Hodgkin Lymphoma (NHL) Market Size 2021-2026 ($ Millions) Figure 58. Japan Non Hodgkin Lymphoma (NHL) Market Size 2021-2026 ($ Millions) Figure 59. Korea Non Hodgkin Lymphoma (NHL) Market Size 2021-2026 ($ Millions) Figure 60. Southeast Asia Non Hodgkin Lymphoma (NHL) Market Size 2021-2026 ($ Millions) Figure 61. India Non Hodgkin Lymphoma (NHL) Market Size 2021-2026 ($ Millions) Figure 62. Australia Non Hodgkin Lymphoma (NHL) Market Size 2021-2026 ($ Millions) Figure 63. Germany Non Hodgkin Lymphoma (NHL) Market Size 2021-2026 ($ Millions) Figure 64. France Non Hodgkin Lymphoma (NHL) Market Size 2021-2026 ($ Millions) Figure 65. UK Non Hodgkin Lymphoma (NHL) Market Size 2021-2026 ($ Millions) Figure 66. Italy Non Hodgkin Lymphoma (NHL) Market Size 2021-2026 ($ Millions) Figure 67. Russia Non Hodgkin Lymphoma (NHL) Market Size 2021-2026 ($ Millions) Figure 68. Spain Non Hodgkin Lymphoma (NHL) Market Size 2021-2026 ($ Millions) Figure 69. Egypt Non Hodgkin Lymphoma (NHL) Market Size 2021-2026 ($ Millions) Figure 70. South Africa Non Hodgkin Lymphoma (NHL) Market Size 2021-2026 ($ Millions) Figure 71. Israel Non Hodgkin Lymphoma (NHL) Market Size 2021-2026 ($ Millions) Figure 72. Turkey Non Hodgkin Lymphoma (NHL) Market Size 2021-2026 ($ Millions) Figure 73. GCC Country Non Hodgkin Lymphoma (NHL) Market Size 2021-2026 ($ Millions) |
| ※본 조사보고서 [세계의 비호지킨 림프종 (NHL) 시장예측 2021년-2026년] (코드 : LPI-2201K02109) 판매에 관한 면책사항을 반드시 확인하세요. |
| ※본 조사보고서 [세계의 비호지킨 림프종 (NHL) 시장예측 2021년-2026년] 에 대해서 E메일 문의는 여기를 클릭하세요. |